{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T06:13:04Z","timestamp":1759558384962,"version":"build-2065373602"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.ejogrb.2017.12.039","type":"journal-article","created":{"date-parts":[[2017,12,20]],"date-time":"2017-12-20T13:21:34Z","timestamp":1513776094000},"page":"140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Letter to the Editor\/Comments on \u201cEndometrial cancer after ulipristal acetate for uterine fibroma\u201d by Ignatov et al. Eur J Obstet Gynecol Reprod Biol 2017; Dec;219:134"],"prefix":"10.1016","volume":"223","author":[{"given":"N.","family":"Chabbert-Buffet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Bergeron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Dara\u00ef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2017.12.039_bib0005","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ejogrb.2017.10.022","article-title":"Endometrial cancer after ulipristal acetate for uterine fibroma","volume":"219","author":"Ignatov","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"8089","key":"10.1016\/j.ejogrb.2017.12.039_bib0010","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0140-6736(78)92895-7","article-title":"Critical assessment of dilatation and curettage in 1029 women","volume":"2","author":"MacKenzie","year":"1978","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ejogrb.2017.12.039_bib0015","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0015-0282(00)01792-1","article-title":"Diagnostic inadequacy of dilatation and curettage","volume":"75","author":"Bettocchi","year":"2001","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.ejogrb.2017.12.039_bib0020","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/01.AOG.0000431815.52679.bb","article-title":"Practice bulletin no. 136: management of abnormal uterine bleeding associated with ovulatory dysfunction","volume":"122","author":"Committee on Practice B-G","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ejogrb.2017.12.039_bib0025","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejogrb.2010.07.016","article-title":"Clinical practice guidelines on menorrhagia: management of abnormal uterine bleeding before menopause","volume":"152","author":"Marret","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211517305912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211517305912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:42:16Z","timestamp":1759556536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211517305912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":5,"alternative-id":["S0301211517305912"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2017.12.039","relation":{},"ISSN":["0301-2115"],"issn-type":[{"type":"print","value":"0301-2115"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Letter to the Editor\/Comments on \u201cEndometrial cancer after ulipristal acetate for uterine fibroma\u201d by Ignatov et al. Eur J Obstet Gynecol Reprod Biol 2017; Dec;219:134","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2017.12.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}